Fratantoni JC, Hall CW, Neufeld EF. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science. 1968;162:570–2.

Article  CAS  PubMed  Google Scholar 

Taylor M, Khan S, Stapleton M, Wang J, Chen J, Wynn R, et al. Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant 2019;25:e226–e46.

Article  Google Scholar 

Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA. Mol Genet Metab Rep. 2014;1:31–41.

Article  PubMed  PubMed Central  Google Scholar 

Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, et al. Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab. 2016;117:84–94.

Article  CAS  PubMed  Google Scholar 

Wang J, Luan Z, Jiang H, Fang J, Qin M, Lee V, et al. Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis-a ten-year report from the china children transplant group. Biol Blood Marrow Transpl. 2016;22:2104–8.

Article  Google Scholar 

Qu Y, Liu H, Wei L, Nie S, Ding W, Liu S, et al. The outcome of allogeneic hematopoietic stem cell transplantation from different donors in recipients with mucopolysaccharidosis. Front Pediatr. 2022;10:877735.

Article  PubMed  PubMed Central  Google Scholar 

Akyol MU, Alden TD, Amartino H, Ashworth J, Belani K, Berger KI, et al. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Orphanet J Rare Dis. 2019;14:137.

Article  PubMed  PubMed Central  Google Scholar 

Northover H, Cowie RA, Wraith JE. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis. 1996;19:357–65.

Article  CAS  PubMed  Google Scholar 

Tomatsu S, Montano AM, Oikawa H, Smith M, Barrera L, Chinen Y, et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol. 2011;12:931–45.

Article  CAS  PubMed  Google Scholar 

Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017;121:227–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet Part A. 2003;123A:310–3.

Article  PubMed  Google Scholar 

Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International morquio A registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis. 2007;30:165–74.

Article  CAS  PubMed  Google Scholar 

Çelik B, Tomatsu SC, Tomatsu S, Khan SA. Epidemiology of mucopolysaccharidoses update. Diagnostics (Basel). 2021;11:273.

Wood TC, Harvey K, Beck M, Burin MG, Chien YH, Church HJ, et al. Diagnosing mucopolysaccharidosis IVA. J Inherit Metab Dis. 2013;36:293–307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terzioglu M, Tokatli A, Coskun T, Emre S. Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene. Hum Mutat. 2002;20:477–8.

Article  PubMed  Google Scholar 

Khedhiri S, Chkioua L, Elcioglu N, Laradi S, Miled A. Mutations and polymorphisms in N-acetylgalactosamine-6-sulfate sulfatase gene in Turkish Morquio A patients. Pathologie-biologie. 2014;62:38–40.

Article  CAS  PubMed  Google Scholar 

Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, et al. International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet Part A. 2015;167A:11–25.

Article  PubMed  Google Scholar 

Montano AM, Tomatsu S, Brusius A, Smith M, Orii T. Growth charts for patients affected with Morquio A disease. Am J Med Genet Part A. 2008;146A:1286–95.

Article  PubMed  Google Scholar 

Tomatsu S, Mackenzie WG, Theroux MC, Mason RW, Thacker MM, Shaffer TH, et al. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review. Res Rep. Endocr Disord. 2012;2012:65–77.

PubMed  PubMed Central  Google Scholar 

Sawamoto K, Suzuki Y, Mackenzie WG, Theroux MC, Pizarro C, Yabe H, et al. Current therapies for Morquio A syndrome and their clinical outcomes. Expert Opin Orphan drugs. 2016;4:941–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi Y, Musson DG, Schweighardt B, Tompkins T, Jesaitis L, Shaywitz AJ, et al. Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome. Clin Pharmacokinetics. 2014;53:1137–47.

Article  CAS  Google Scholar 

Tomatsu S, Montano AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2008;17:815–24.

Article  CAS  PubMed  Google Scholar 

Pizarro C, Davies RR, Theroux M, Spurrier EA, Averill LW, Tomatsu S. Surgical reconstruction for severe tracheal obstruction in Morquio A syndrome. Ann Thorac Surg. 2016;102:e329–31.

Article  PubMed  Google Scholar 

Doherty C, Stapleton M, Piechnik M, Mason RW, Mackenzie WG, Yamaguchi S, et al. Effect of enzyme replacement therapy on the growth of patients with Morquio A. J Hum Genet. 2019;64:625–35.

Article  PubMed  Google Scholar 

Frigeni M, Rodriguez-Buritica DF, Saavedra H, Gunther KA, Hillman PR, Balaguru D, et al. The youngest pair of siblings with Mucopolysaccharidosis type IVA to receive enzyme replacement therapy to date: A case report. Am J Med Genet Part A. 2021;185:3510–6.

Article  PubMed  Google Scholar 

Do Cao J, Wiedemann A, Quinaux T, Battaglia-Hsu SF, Mainard L, Froissart R, et al. 30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: About one case. Mol Genet Metab Rep. 2016;9:42–5.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura-Utsunomiya A, Nakamae T, Kagawa R, Karakawa S, Sakata S, Sakura F, et al. A case report of a Japanese boy with Morquio A syndrome: effects of enzyme replacement therapy initiated at the age of 24 months. Int J Mol Sci. 2020;21:989.

Sawamoto K, Álvarez González JV, Piechnik M, Otero FJ, Couce ML, Suzuki Y, et al. Mucopolysaccharidosis IVA: diagnosis, treatment, and management. Int J Mol Sci. 2020;21:1517.

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O172). Bone marrow transplantation. 2023; 58: 20-152.

Tanjuakio J, Suzuki Y, Patel P, Yasuda E, Kubaski F, Tanaka A, et al. Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation. Mol Genet Metab. 2015;114:161–9.

Article  CAS  PubMed  Google Scholar 

Zanetti A, D’Avanzo F, AlSayed M, Brusius-Facchin AC, Chien YH, Giugliani R, et al. Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome):a review and classification of GALNS gene variants and reporting of 68 novel variants. Hum Mutat. 2021;42:1384–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013;121:3981–7.

Article  CAS  PubMed  PubMed Central  Google Scholar